Skip to main content
. Author manuscript; available in PMC: 2018 Jun 8.
Published in final edited form as: Exp Eye Res. 2018 Mar 1;170:169–176. doi: 10.1016/j.exer.2018.02.026

Fig. 1. Egfl7/miR-126 promoter activity during choroidal vascular development.

Fig. 1

(A) Cross section of 5.5 kb pEgfl7/miR-126-LacZ transgenic E9.5 embryo showing Endomucin staining surrounding optical vesicle; (B) Sample in (A) co-stained with LacZ antibody; (C) Merge of (A) and (B); (D) Cross section of 5.5 kb pEgfl7/miR-126-LacZ transgenic E10.5 embryo showing Endomucin staining behind the prospective RPE. Several labeled regions are: 1: prospective RPE, 2: prospective retina, 3: lens vesicle; (E) Sample in (D) co-stained with LacZ antibody; (F) Merge of (D) and (E) with boxed region highlighted in the insert in the right upper corner; (G) Cross section of 5.5 kb pEgfl7/miR-126-LacZ transgenic E13.5 embryo showing Endomucin staining behind the RPE. Lens, hyaloid vessel and retina structures are labeled; (H) Sample in (G) co-stained with LacZ antibody; (I) Merge of (G) and (H). scale bar equals 200µm.